OIM
ADAP
Oracle Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-52,921
| Closed | -$304K | – | 15 |
|
|
2018
Q4 | $304K | Sell |
52,921
-844,573
| -94% | -$4.85M | 0.09% | 15 |
|
|
2018
Q3 | $12.2M | Sell |
897,494
-496,249
| -36% | -$6.73M | 2.66% | 8 |
|
|
2018
Q2 | $16.5M | Buy |
1,393,743
+63,673
| +5% | +$756K | 4% | 6 |
|
|
2018
Q1 | $14.9M | Buy |
1,330,070
+297,349
| +29% | +$3.34M | 3.62% | 7 |
|
|
2017
Q4 | $6.9M | Buy |
1,032,721
+330,860
| +47% | +$2.21M | 1.37% | 10 |
|
|
2017
Q3 | $5.75M | Buy |
+701,861
| New | +$5.75M | 0.94% | 12 |
|